Navigation Links
Abaxis Reports Record Revenues and Operating Income for the Second Quarter of Fiscal 2009
Date:10/27/2008

fiscal 2009 were $19.9 million, an increase of 11 percent over last year's comparable quarter. Additionally, veterinary reagent disc sales for the second quarter of fiscal 2009 were $13.7 million, an increase of 18 percent compared to the same period last year.

The company ended the quarter with $69.6 million in cash, cash equivalents and short-term investments. As of September 30, 2008, the company had a total of $35.0 million in short-term investments, consisting of $28.0 million in auction rate securities. As of September 30, 2008, unrealized loss on investments, net of related income taxes of $393,000, are temporary and reported as a component of accumulated other comprehensive loss.

Clint Severson, chairman and chief executive officer of Abaxis, commented, "We had a very solid quarter with double-digit growth in both revenues and net income -- 10 percent and 14 percent respectively -- and gross margins of 55.4 percent. Total medical and veterinary reagent disc unit sales during the quarter were up 16 percent compared to last year's second quarter; led by an increase in medical reagent disc unit sales of 28 percent; and by sales of more than one million veterinary reagent discs in a quarter for the first time in Abaxis' history. We are very pleased with these results."

"This was also a pivotal quarter in the history of the company," continued Mr. Severson, "in that we believe we have successfully addressed the manufacturing, hardware and software issues of the recent past. The focus and the dedication of our entire team now positions Abaxis to produce and market best-of-breed point-of-care products with increased levels of accuracy, reliability and efficiency. With a strong balance sheet, no long-term debt and a commitment to deliver quality solutions we believe that the future is bright."

Conference Call

Abaxis has scheduled a conference call to discuss its results at 4:15 p.m. Eastern Time on October 27, 2008. Participants ca
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
2. Abaxis Reports Financial Performance for the First Quarter of Fiscal 2009
3. Abaxis to Report Third Quarter Fiscal 2008 Financial Results Thursday, January 31, 2008
4. Abaxis CEO Clint Severson Named Entrepreneur of the Year by Forbes Magazine
5. Abaxis to Present at the Sidoti & Company Sixth Annual San Francisco Institutional Investor Forum Conference
6. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
7. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
8. International Drug & Explosive Detection Firm Identa Corp Releasing: Jant Pharmacal Corporation Reports Successful Market Penetration of the Accutest(R) IDenta Co-brand in the United States and Oversees
9. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
10. Aware, Inc. Reports Third Quarter 2008 Financial Results
11. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... 2014 The SNIS Foundation recognized its ... fund a translational research project.  The first award ... was presented at the Society of NeuroInterventional Surgery ... Colorado Springs, CO. ... neurovascular conditions, SNIS formed the SNIS Foundation, in ...
(Date:7/31/2014)... 31, 2014 Graphite Metallizing Corporation announces ... oven carts. These bearings are uniquely suited to prevent ... bearings because of the high temperatures . , ... from the design engineers at Graphite Metallizing to overcome ... During their manufacturing operation, pans containing blocks of powder ...
(Date:7/31/2014)... DUBLIN , July 31, 2014 ... the "Global Genomics Market 2014-2018" report to ... Genomics is the study of the genetic ... to be a strong basis for the discovery and ... of human diseases or health conditions. Genomics is supported ...
(Date:7/31/2014)... , July 31, 2014  Smith & ... global medical technology business, today announced its entry ... the HAT-TRICK™ Lesser Toe Repair System. Comprised of ... products for metatarsophalangeal (MTP) ligament repair and reconstruction, ... implant for proximal Inter-phalanges (PIP) fusion, also known ...
Breaking Biology Technology:SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 2SNIS Foundation Bestows First Grant Award For Cutting-Edge NeuroInterventional Research 3Graphite Metallizing Announces Bearings for High Temperature Oven Applications 2Graphite Metallizing Announces Bearings for High Temperature Oven Applications 3Global Genomics Market 2014-2018: Key Vendors are F. Hoffmann-La Roche, Life Technologies, Qiagen and Illumina 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 2Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 3Smith & Nephew scores a HAT-TRICK with its entry into the high-growth hammer toe repair market 4
... Feb. 16, 2012  BioDelivery Sciences International, Inc. (Nasdaq: ... Office (USPTO) has issued a Notice of Allowance of ... will extend the exclusivity of the BioErodible MucoAdhesive (BEMA) ... from 2020 to 2027.  A Notice ...
... ANN ARBOR, Mich., Feb. 16, 2012  Adeona Pharmaceuticals, Inc. ... synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious ... meeting of stockholders to change its corporate name to ... shares will start trading under its new name and ...
... University of British Columbia professor has developed a new class ... sudden loss of consciousness in rats, and which are ... as "petit mal seizures," are a symptom of epilepsy, most ... awake but dazed. The seizures, arising from a flurry of ...
Cached Biology Technology:BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals 2BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals 3BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals 4BioDelivery Sciences Receives Patent Allowance Triggering $15 Million Milestone Payment from Endo Pharmaceuticals 5New drugs show promise for preventing 'absence seizures' in children: UBC research 2
(Date:7/31/2014)... many of the roughly 156,000 gas stations across ... in parts of underground gas storage tankscorrosion that ... groundwater, a source of drinking water. In recent ... many rapidly corroding gas storage tank components such ... with use of gasoline-ethanol blends and the presence ...
(Date:7/31/2014)... Neb., July 31, 2014 -- Do people make a ... mothers raise them that way? Is it a matter ... Nebraska-Lincoln and a colleague from Rice University say that ... some people lean left while others lean right. , ... and deep-seated psychology are at the core of political ...
(Date:7/31/2014)... as the Rim Fire was in full fury, raging ... it entered the backcountry of Yosemite National Park in ... the park, the battle began to turn, enacting a ... can combine to fuel large, severe fires. , "When ... lands where fire had been used as a management ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2Scientists find growing consensus: Political attitudes derive from body and mind 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5
... researchers at Scottsdale Healthcare and TGen today announced the ... patients battling cancer. The Phase I clinical ... of the American Association for Cancer Research by Daniel ... (BCC) and pancreatic cancer. The Arizona trials were conducted ...
... This release is available in French . ... Generation Investment Management, the private bankers Lombard Odier Darier ... new chair at EPFL dedicated to sustainable development. The ... education between fundamental and social sciences in the environmental ...
... April 2008 -- European breast cancer specialists have taken ... breast cancer by bringing together world leaders in breast ... meeting, IMPAKT (IMProving cAre and Knowledge in Translational ... held 7-9 May 2009 in Brussels, Belgium, is designed ...
Cached Biology News:2 new therapies show promise for cancer patients 22 new therapies show promise for cancer patients 3EPFL Research Day 2008, in the presence of Al Gore 2EPFL Research Day 2008, in the presence of Al Gore 3Improving care and knowledge in translational research to fight breast cancer 2
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity....
...
Water Distilled (Gibco™) is membrane filtered and endotoxin screened....
The S. cerevisiae Hansen strains are the parental yeast strains from which the deletions were derived....
Biology Products: